(Q34453304)

2 August 2017

1 reference

title

Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer (English)

1 reference

2 August 2017

0 references

B Shannan

1

1 reference

2 August 2017

M Seifert

2

1 reference

2 August 2017

K Leskov

3

1 reference

2 August 2017

J Willis

4

1 reference

2 August 2017

D Boothman

5

1 reference

2 August 2017

W Tilgen

6

1 reference

2 August 2017

J Reichrath

7

1 reference

2 August 2017

publication date

1 January 2006

1 reference

Cell Death & Differentiation

2 August 2017

published in

1 reference

2 August 2017

volume

13

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

12-19

1 reference

Clusterin/apolipoprotein J in human aging and cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Modulation of different clusterin isoforms in human colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Synthesis and functional analyses of nuclear clusterin, a cell death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Transforming growth factor beta regulates clusterin gene expression via modulation of transcription factor c-Fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Isolation of Ku70-binding proteins (KUBs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Repression of IR-Inducible Clusterin Expression by the p53 Tumor Suppressor Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Vitamin D and systemic cancer: is this relevant to malignant melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

When X-ray-inducible proteins meet DNA double strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Characterization of a vitamin D3-resistant MCF-7 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Overexpression of clusterin in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Clusterin as a biomarker in murine and human intestinal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Antisense therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Clusterin and IGFBPs as antisense targets in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Clusterin Biogenesis Is Altered during Apoptosis in the Regressing Rat Ventral Prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Clusterin expression within skin correlates with hair growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Transforming growth factor beta-1 up-regulates clusterin synthesis in thyroid epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Expression of clusterin in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Clusterin expression in malignant lymphomas: a survey of 266 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Antisense clusterin oligodeoxynucleotides increase the response ofHER-2 gene amplified breast cancer cells to Trastuzumab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401779

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401779

1 reference

2 August 2017

1 reference